A naturalistic analysis of rTMS treatment outcomes for major depressive disorder in West Australian youth.

ABSTRACT:

Objective

Repetitive transcranial magnetic stimulation (rTMS) is an effective, evidence-based treatment for major depressive disorder (MDD) in adults and is publicly funded in Australia. However, there is limited data as to its efficacy and safety in treating MDD in adolescent and youth populations.

Methods

This retrospective report examined routinely collected data of 46 outpatients aged 17 to 25 years old, who received rTMS treatment for MDD in a private TMS clinic. Primary outcomes measures were the Montgomery-Asberg Depression Rating Scale (MADRS) and the depression subscale of the 21-item Depression, Anxiety and Stress Scale (DASS-21). Secondary measures included the anxiety and stress sub-scales of the DASS-21, a measure of Quality of Life (QoL) Enjoyment and Satisfact

SUBMITTER: Miljevic A 

PROVIDER: S-EPMC11913841 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature